Midterm #3: Complement System Flashcards
1
Q
Complement System relationship to Immune System
A
- Part of innate immunity but closely related to adaptive immune system
2
Q
Complement factors can be proteolytically cleaved
A
- A (small)
- B (large)
3
Q
Initiation and 3 Main outcomes of Complement system
A
- Initations: antibodies bound to antigen, or binding complement factor to pathogen surface
- 3 Major Outcomes:
- 1: Inflammation: Complement stimulate basophil and mast cell degranulation. C5a is also a chemokine, attracting cells of the immune system to the site of infection
- 2: Opsonisation: Complement factor 3b coats foreign organsims, which stimulates phagocytosis by WBC.
- 3: Pathogen Lysis: Complement C5b initate steps to create MAC
- Also plays role in solubuilizing and removing immune complexes
4
Q
Antibody Structure
A
- IgG have 2 heavy and 2 light chains, each with variable and constant domains
- Antigen binding sites (aka complementarity determining regions) are located on variable region of light and heavy chain
- Fc region composed of constant domain of heavy chain and binding site for immune cell receptors and complement factors
- Therapeutic antibodies may consist of entire IgG (cetuximab), isolated Fab fragments (ranibizumab), or single-chain variable fragments (scFv e.g. pexelizumab)
5
Q
The Classical Complement Pathway
A
- aka the antibody dependent complement pathway
- Triggered by C1 binding to Fc region
- activates it
- Cleaves C2 into C2a and C2b and C4 into C4a and C4b
- C4a stimulates an inflammation response
- it is an anaphylatoxin
- C4b and C2b form a complex C4b2b that is also called C3 convertase
6
Q
The Lectin Pathway
A
- Pathogens recognized by their pathogen-derived carbohydrates
- Recognized by mannann-binding lectin (MBL)
- pattern recognition receptor
- MBL:carb compex recruits MBL-associated serine proteases (MASPs) related to C1 complex
- MASP activate C4 and C2 resulting in C4b2b complex and C4a anaphylatoxin
7
Q
Activation of C3: The Central Step
A
- C4b2b bind C3 and cleaves it to C3a and C3b
- C3a is small chemokine that stimulate chemotaxis of phagocytes
- also anaphylatoxin stimulating degranulation by basophils and mast cells
- C3b remains associated with pathogen and can act as opsonin
8
Q
Alternative Complement Pathway
A
- AKA intrinsic complement pathway
- Constituively active
- C3 has low levels of autoproteolytic activity, so small amounts of C3b are present
- When C3b binds pathogen, recruits factor B and factor P to form C3bBb complex (alternative C3 convertase)
- C3bBb can cleave C3 to C3a and C3b
-
Feedback activation/positive feedback
- Enables rapid immune response to pathogens even if the adaptive immune system has not yet mounted an antibody response
- It greatly amplifies the effects of the classical complement pathway and lectin patway
9
Q
C5 Activation and the Membrane Attack Complex
A
- C3b protease that can activate C5 into C5a and C5b
- C5a is an anaphylatoxin and chemokine
- C5b recruits other complement factors (C6, C7, C8 , C9) to form a pore in the bacterial membrane called the membrane attack complex
- cell lysis and death in antibody independent manner
- MAC in host cell inhibited by CD59
- certain viruses incorporate this into envelops to protects themselves
10
Q
The Complete Complement Cascade
A
- 3 Routes to Stimulate:
- Recognition of antibody:antigen complexes by C1 binding to Fc region of the Ab
- Recognition of pathogen-derived carbohydrates by MBL
- C3b binding to pathogen surfaces in the alternative pathway
- 3 Outcomes:
- Chemokine and anaphylatoxin activity to stimulate inflammation and recruitment of immune system cells
- opsoinazation to enhance phagocytosis
- MAC
11
Q
Control of the Complement System
A
- Factors H and I in the plasma inactivate C3b in solution but not those bound to pathogen
- C3b bound to a bacterial cell is maintained in an active state by Factor P
- Complement is also closely linked to coagulation, adaptive immunity, wound repair and other biologically important pathways
12
Q
Complement Disorders
A
- Factor P deficiency and recurrent bacterial infections
- Deficiencies in classical pathway linked to systemic lupus erythematosus (SLE)
- thought to result from defect in clearance of immune complexes
- Overactivation of complement system could cause inflammatory diseases
- complement inhibitors like pexelizumab (C5 inhibitor) are under active investigation